New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Larimar Therapeutics, Inc.
LRMR
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

162M

Biotechnology

Next Earning date - 27 Mar 2025

162M

Biotechnology

Next Earning date - 27 Mar 2025

3.31USD

Shape0.03 ( 0.91%)
Market Closed (as of Feb 19, 21:00 EDT)
favorite-chart

Relative Strenght

5
favorite-chart

Volume Buzz

-1%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

70%

Quote Panel

Shape
Updated March 23, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

LRMR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$1.63

Shape-581%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Oppenheimer

initialise

Previous: Not converted

2024-10-15

Now: Outperform

Wedbush

initialise

Previous: Not converted

2024-10-03

Now: Outperform

H.C. Wainwright

initialise

Previous: Not converted

2024-10-02

Now: Buy

Citigroup

initialise

Previous: Not converted

2022-12-13

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.21
vs -0.50

Q1.23

arrow
arrow

N/A

-0.15
vs -0.49

Q2.23

arrow
arrow

N/A

-0.19
vs -0.47

Q3.23

arrow
arrow

N/A

-0.21
vs -0.37

Q4.23

arrow
arrow

N/A

-0.30
vs -0.21

Q1.24

arrow
arrow

N/A

-0.27
vs -0.15

Q2.24

arrow
arrow

N/A

-0.34
vs -0.19

Q3.24

arrow
arrow

N/A

-0.24
vs -0.21

Q4.24

arrow
arrow

N/A

-0.32
vs -0.30

Q1.25

arrow
arrow

N/A

-0.35
vs -0.27

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-8%

-0.08
vs -0.07

Q1.23

arrow
arrow

-5%

-0.05
vs -0.08

Q2.23

arrow
arrow

-8%

-0.08
vs -0.05

Q3.23

arrow
arrow

-10%

-0.10
vs -0.08

Q4.23

arrow
arrow

-16%

-0.16
vs -0.10

Q1.24

arrow
arrow

-6%

-0.06
vs -0.16

Q2.24

arrow
arrow

-10%

-0.10
vs -0.06

Q3.24

arrow
arrow

-8%

-0.08
vs -0.10

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

69

69
vs 48

44%

Q2.23

arrow
arrow

67

67
vs 69

-3%

Q3.23

arrow
arrow

67

67
vs 67

NA

Q4.23

arrow
arrow

74

74
vs 67

10%

Q1.24

arrow
arrow

112

112
vs 74

51%

Q2.24

arrow
arrow

110

110
vs 112

-2%

Q3.24

arrow
arrow

127

127
vs 110

15%

Q4.24

arrow
arrow

122

122
vs 127

-4%

Earnings Growth

Latest News